doi: 10.3389/fimmu.2025.1567980 Received 28 January 2025 Accepted 07 July 2025 Published 22 July 2025 Volume 16 - 2025 Edited by Lulong Bo, Navy Medical University, China Reviewed by Hao Zhang, Fudan University, China Updates Copyright 2025 Yao, Liao, Liu, Zhao, Song, Huang and Wang
Considering these advantages, ferroptosis is expected to become a promising therapeutic strategy for drug-resistant tumors in the near future, either alone or in combination
Oral Supplements Injections act faster and are more reliable in people with absorption issues, while oral supplements can be effective in mild deficiency
Any program that does not prominently feature semaglutide and tirzepatide training is outdated